Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
By Allison Gatlin
Oxford's Covid-19 Vaccine Is the Coronavirus Front-Runner
By Stephanie Baker
China's Sinopharm launches Phase III trial of Covid-19 vaccine in UAE
By Divya Tirumalaraju
First data for Moderna Covid-19 vaccine show it spurs an immune response
By Matthew Herper & Damian Garde